Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

Matthew S. Davids, Ulrich Jäger, Nicole Lamanna et al.|Clinical Cancer Research|2020

Cited by 43